Bruce D Gaynor

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Travel and implications for the elimination of trachoma in ethiopia
    Neelima A Shah
    Department of Public Health Sciences, University of California, Davis, California, USA
    Ophthalmic Epidemiol 17:113-7. 2010
  2. ncbi A rationale for continuing mass antibiotic distributions for trachoma
    Kathryn J Ray
    Francis I, Proctor Foundation, University of California, San Francisco, CA, USA
    BMC Infect Dis 7:91. 2007
  3. ncbi Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions
    Jeremy D Keenan
    F I Proctor Foundation, 513 Parnassus Avenue, Med Sci S309, Box 0412, University of California, San Francisco, San Francisco, CA 94143 0412, USA
    Invest Ophthalmol Vis Sci 53:235-40. 2012
  4. ncbi Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma
    Jeremy D Keenan
    Department of Ophthalmology, University of California, San Francisco, CA, USA
    Am J Trop Med Hyg 82:482-7. 2010
  5. ncbi Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma
    Jaya D Chidambaram
    F. I. Proctor Foundation, University of California, San Francisco, CA 94143-0412, USA
    JAMA 295:1142-6. 2006
  6. ncbi Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions
    Jesse B Biebesheimer
    FI Proctor Foundation, University of California, San Francisco, California 94143 0412, USA
    Ophthalmology 116:2047-50. 2009
  7. ncbi The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma
    Sara Haug
    FI Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California 94143 0944, USA
    Clin Infect Dis 51:571-4. 2010
  8. ncbi Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma
    Jeremy D Keenan
    FI Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, CA 94143 0412, USA
    Clin Infect Dis 54:253-6. 2012
  9. ncbi Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial
    Jenafir I House
    FI Proctor Foundation, University of California, San Francisco, USA
    Lancet 373:1111-8. 2009
  10. ncbi Mass antibiotic treatment and community protection in trachoma control programs
    Jaya D Chidambaram
    F. I. Proctor Foundation for Research in Ophthalmology, University of California, San Francisco, CA 94143-0944, USA
    Clin Infect Dis 39:e95-7. 2004

Collaborators

Detail Information

Publications14

  1. ncbi Travel and implications for the elimination of trachoma in ethiopia
    Neelima A Shah
    Department of Public Health Sciences, University of California, Davis, California, USA
    Ophthalmic Epidemiol 17:113-7. 2010
    ..Seven hundred and seventeen households with at least one child aged 1-5 years in 48 villages were surveyed to collect the details of travel in 1 month prior to the survey...
  2. ncbi A rationale for continuing mass antibiotic distributions for trachoma
    Kathryn J Ray
    Francis I, Proctor Foundation, University of California, San Francisco, CA, USA
    BMC Infect Dis 7:91. 2007
    ..Here we use mathematical models to demonstrate that repeated antibiotic distributions can eliminate infection in a reasonable time period...
  3. ncbi Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions
    Jeremy D Keenan
    F I Proctor Foundation, 513 Parnassus Avenue, Med Sci S309, Box 0412, University of California, San Francisco, San Francisco, CA 94143 0412, USA
    Invest Ophthalmol Vis Sci 53:235-40. 2012
    ....
  4. ncbi Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma
    Jeremy D Keenan
    Department of Ophthalmology, University of California, San Francisco, CA, USA
    Am J Trop Med Hyg 82:482-7. 2010
    ....
  5. ncbi Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma
    Jaya D Chidambaram
    F. I. Proctor Foundation, University of California, San Francisco, CA 94143-0412, USA
    JAMA 295:1142-6. 2006
    ..Repeated treatments or other effective measures will be necessary for elimination...
  6. ncbi Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions
    Jesse B Biebesheimer
    FI Proctor Foundation, University of California, San Francisco, California 94143 0412, USA
    Ophthalmology 116:2047-50. 2009
    ..To determine whether infectious trachoma can be completely eliminated from severely affected villages...
  7. ncbi The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma
    Sara Haug
    FI Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California 94143 0944, USA
    Clin Infect Dis 51:571-4. 2010
    ..6% (95% CI, 18.8%-40.4%; P <.001 ) and 20.8% (95% CI, 12.7%-30.7%; P < .001), respectively. Macrolide resistance decreases after antibiotic pressure is removed...
  8. ncbi Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma
    Jeremy D Keenan
    FI Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, CA 94143 0412, USA
    Clin Infect Dis 54:253-6. 2012
    ..An RNA-based test detected ocular chlamydial infection in more children than did a DNA-based test (6.9% vs 4.2%), and in a larger number of communities (8 vs 7)...
  9. ncbi Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial
    Jenafir I House
    FI Proctor Foundation, University of California, San Francisco, USA
    Lancet 373:1111-8. 2009
    ..We assessed indirect protection against trachoma with mass azithromycin distributions...
  10. ncbi Mass antibiotic treatment and community protection in trachoma control programs
    Jaya D Chidambaram
    F. I. Proctor Foundation for Research in Ophthalmology, University of California, San Francisco, CA 94143-0944, USA
    Clin Infect Dis 39:e95-7. 2004
    ..Similarities with the indirect protection within a treated community (i.e., "herd protection") that has been observed in vaccination programs are discussed...
  11. ncbi Practice patterns and opinions in the treatment of acanthamoeba keratitis
    Catherine E Oldenburg
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143 0944, USA
    Cornea 30:1363-8. 2011
    ..Management of acanthamoeba keratitis remains challenging for ophthalmologists. We conducted a survey of members of The Cornea Society to elicit expert opinions on the diagnosis and treatment of acanthamoeba keratitis...
  12. ncbi Childhood mortality in a cohort treated with mass azithromycin for trachoma
    Jeremy D Keenan
    F I Proctor Foundation, San Francisco, CA, USA
    Clin Infect Dis 52:883-8. 2011
    ..Here, we monitor a large cohort in which almost 90% of individuals received azithromycin. We assess whether receiving treatment is associated with reduced all-cause and infectious childhood mortality...
  13. ncbi Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial
    Alison H Skalet
    Francis I Proctor Foundation for Research in Opthalmology, University of California, San Francisco, San Francisco, California, United States of America
    PLoS Med 7:e1000377. 2010
    ..In this study, we used a randomized clinical trial design to assess whether macrolide resistance was higher in communities treated with mass azithromycin for trachoma, compared to untreated control communities...
  14. ncbi Rationale for mass antibiotic distribution for trachoma elimination
    Bruce D Gaynor
    Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143, USA
    Int Ophthalmol Clin 42:85-92. 2002